NLS Intellectual Property

The Swedish medical image company ContextVision has filed a patent for a new method using high-precision deep learning with digital pathology. The market for their method is estimated to be worth $157 million by 2018. This method allows the company to develop new, unique decision support tools based on true data instead of subjective evaluations. […]

Targovax has announced that the US Patent and Trademark office has granted US patent no 9,345,787 for Targovax’ lead viral product ONCOS-102. ONCOS-102 is a purposefully engineered human serotype 5 adenovirus optimized to induce systemic anti-tumor T cell response in cancer patients. “This patent is an important component of Targovax’s intellectual property portfolio covering specific […]

Cantargia AB’s patent application for IL1RAP as target molecule for antibody-based therapies and diagnostics of solid tumours has been approved by the Japan Patent Office (JPO). The patent approval (patent no. 5940093) refers to the company’s method of using IL1RAP as target molecule for treatment of the vast majority of solid tumours. The approved patent includes those […]

The 2015 Nobel Prize in Chemistry honored discoveries about DNA repair that have given us fundamental knowledge of how a living cell functions and are, for instance, used for the development of new cancer treatments. Linus Plym Forshell, PhD, MSc, at the Swedish Patent and Registration Office, provided us with some insight about what is […]

SpinChem AB in Umeå has been granted several new patents relating to the construction of its proprietary rotating bed reactors (RBR) and their use in chemical and biological processes. The applications of the RBR technology are numerous. Examples can be found in the production of biodiesel, the production of fermented beverages and the manufacturing of […]

Oslo Cancer Cluster member Photocure announces that a new patent for Cevira has been granted in Europe. Cevira is one of Photocure’s promising pipeline products and is being developed as a new and innovative breakthrough for the treatment of precancerous lesions of the cervix. The newly granted patent protects the Cevira drug, its use and […]